{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:15:18Z","timestamp":1775736918047,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Recep Tayyip Erdo\u011fan University Development Foundation","award":["02025005012477"],"award-info":[{"award-number":["02025005012477"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21845-2","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:20:02Z","timestamp":1761830402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum GDF15 as a supportive biomarker in female fibromyalgia patients based on a prospective case-control study"],"prefix":"10.1038","volume":"15","author":[{"given":"Ertugrul","family":"Yigit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Cure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Huner Yigit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakki","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"21845_CR1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw, D. J. Fibromyalgia: a clinical review. JAMA 311, 1547\u20131555. https:\/\/doi.org\/10.1001\/jama.2014.3266 (2014).","journal-title":"JAMA"},{"key":"21845_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.55563\/clinexprheumatol\/oo5zjo","volume":"42","author":"O Cure","year":"2024","unstructured":"Cure, O. et al. Effect of fibromyalgia on demographic, biochemical, metabolic and inflammatory profiles: a single-centre retrospective study. Clin. Exp. Rheumatol. 42, 1205\u20131214. https:\/\/doi.org\/10.55563\/clinexprheumatol\/oo5zjo (2024).","journal-title":"Clin. Exp. Rheumatol."},{"key":"21845_CR3","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","volume":"1","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user, W. et al. Nat. Rev. Dis. Primers 1, 15022 https:\/\/doi.org\/10.1038\/nrdp.2015.22 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"21845_CR4","doi-asserted-by":"publisher","unstructured":"Bellato, E. et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res. Treat. 426130. https:\/\/doi.org\/10.1155\/2012\/426130 (2012).","DOI":"10.1155\/2012\/426130"},{"key":"21845_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe, F. et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 33, 160\u2013172. https:\/\/doi.org\/10.1002\/art.1780330203 (1990).","journal-title":"Arthritis Rheum."},{"issue":"3","key":"21845_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe, F. et al. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 46 (3), 319\u2013329. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.012 (2016).","journal-title":"Semin Arthritis Rheum."},{"key":"21845_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3899\/jrheum.170095","volume":"44","author":"JN Ablin","year":"2017","unstructured":"Ablin, J. N. & Wolfe, F. A comparative evaluation of the 2011 and 2016 criteria for fibromyalgia. J. Rheumatol. 44, 1271\u20131276. https:\/\/doi.org\/10.3899\/jrheum.170095 (2017).","journal-title":"J. Rheumatol."},{"key":"21845_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/pm\/pnx155","volume":"19","author":"R Gittins","year":"2018","unstructured":"Gittins, R. et al. The accuracy of a fibromyalgia diagnosis in general practice. Pain Med. 19, 491\u2013498. https:\/\/doi.org\/10.1093\/pm\/pnx155 (2018).","journal-title":"Pain Med."},{"key":"21845_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/pm\/pnx271","volume":"19","author":"D Kumbhare","year":"2018","unstructured":"Kumbhare, D. et al. A survey of physicians\u2019 knowledge and adherence to the diagnostic criteria for fibromyalgia. Pain Med. 19, 1254\u20131264. https:\/\/doi.org\/10.1093\/pm\/pnx271 (2018).","journal-title":"Pain Med."},{"key":"21845_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/cells14040271","volume":"14","author":"M Garc\u00eda-Dom\u00ednguez","year":"2025","unstructured":"Garc\u00eda-Dom\u00ednguez, M. Fibromyalgia and inflammation: unrevealing the connection. Cells 14, 271. https:\/\/doi.org\/10.3390\/cells14040271 (2025).","journal-title":"Cells"},{"key":"21845_CR11","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/j.pain.0000000000002927","volume":"164","author":"C Mueller","year":"2023","unstructured":"Mueller, C. et al. Evidence of neuroinflammation in fibromyalgia syndrome: a [\u00b9\u2078F]DPA-714 positron emission tomography study. Pain 164, 2285\u20132295. https:\/\/doi.org\/10.1097\/j.pain.0000000000002927 (2023).","journal-title":"Pain"},{"key":"21845_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai, V. W. W. et al. The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell. Metab. 28, 353\u2013368. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.018 (2018).","journal-title":"Cell. Metab."},{"key":"21845_CR13","doi-asserted-by":"publisher","first-page":"630818","DOI":"10.3389\/fcvm.2021.630818","volume":"8","author":"JW Luo","year":"2021","unstructured":"Luo, J. W. et al. A meta-analysis of growth differentiation factor-15 and prognosis in chronic heart failure. Front. Cardiovasc. Med. 8, 630818. https:\/\/doi.org\/10.3389\/fcvm.2021.630818 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"21845_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/clc.23159","volume":"42","author":"S Xie","year":"2019","unstructured":"Xie, S., Lu, L. & Liu, L. Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: a meta-analysis of prospective studies. Clin. Cardiol. 42, 513\u2013523. https:\/\/doi.org\/10.1002\/clc.23159 (2019).","journal-title":"Clin. Cardiol."},{"key":"21845_CR15","doi-asserted-by":"publisher","first-page":"glae163","DOI":"10.1093\/gerona\/glae163","volume":"79","author":"R Le\u00f3n-Gonz\u00e1lez","year":"2024","unstructured":"Le\u00f3n-Gonz\u00e1lez, R. et al. Growth differentiation factor 15 as a biomarker of cardiovascular risk in chronic musculoskeletal pain. J. Gerontol. Biol. Sci. Med. Sci. 79, glae163. https:\/\/doi.org\/10.1093\/gerona\/glae163 (2024).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"key":"21845_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2147\/JIR.S350281","volume":"15","author":"YW He","year":"2022","unstructured":"He, Y. W. & He, C. S. Association of growth and differentiation factor 15 in rheumatoid arthritis. J. Inflamm. Res. 15, 1173\u20131181. https:\/\/doi.org\/10.2147\/JIR.S350281 (2022).","journal-title":"J. Inflamm. Res."},{"key":"21845_CR17","doi-asserted-by":"publisher","first-page":"926373","DOI":"10.3389\/fimmu.2022.926373","volume":"13","author":"WD Xu","year":"2022","unstructured":"Xu, W. D. et al. GDF-15: a potential biomarker and therapeutic target in systemic lupus erythematosus. Front. Immunol. 13, 926373. https:\/\/doi.org\/10.3389\/fimmu.2022.926373 (2022).","journal-title":"Front. Immunol."},{"issue":"Suppl 74","key":"21845_CR18","first-page":"117","volume":"30","author":"C Iannuccelli","year":"2012","unstructured":"Iannuccelli, C. et al. Fatigue and widespread pain in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: symptoms of the inflammatory disease or associated fibromyalgia? Clin. Exp. Rheumatol. 30 (Suppl 74), 117\u2013121 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"21845_CR19","doi-asserted-by":"publisher","first-page":"e64011","DOI":"10.7759\/cureus.64011","volume":"16","author":"H El-Kasmi","year":"2024","unstructured":"El-Kasmi, H. et al. The prevalence of fibromyalgia in rheumatoid arthritis patients using the fibromyalgia assessment screening tool (FAST 4) based on the multidimensional health assessment questionnaire (MDHAQ). Cureus 16, e64011. https:\/\/doi.org\/10.7759\/cureus.64011 (2024).","journal-title":"Cureus"},{"key":"21845_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053 (2013).","journal-title":"JAMA"},{"key":"21845_CR21","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar2783","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett, R. M. et al. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res. Ther. 11, R120. https:\/\/doi.org\/10.1186\/ar2783 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"21845_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12874-015-0009-y","volume":"15","author":"M Rota","year":"2015","unstructured":"Rota, M., Antolini, L. & Valsecchi, M. G. Optimal cut-point definition in biomarkers: the case of censored failure time outcome. BMC Med. Res. Methodol. 15, 24. https:\/\/doi.org\/10.1186\/s12874-015-0009-y (2015).","journal-title":"BMC Med. Res. Methodol."},{"key":"21845_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/diagnostics11020156","volume":"11","author":"KV Hackshaw","year":"2021","unstructured":"Hackshaw, K. V. The search for biomarkers in fibromyalgia. Diagnostics 11, 156. https:\/\/doi.org\/10.3390\/diagnostics11020156 (2021).","journal-title":"Diagnostics"},{"key":"21845_CR24","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.3390\/jcm9113527","volume":"9","author":"B Gerdle","year":"2020","unstructured":"Gerdle, B. et al. Evidence of mitochondrial dysfunction in fibromyalgia: deviating muscle energy metabolism detected using Microdialysis and magnetic resonance. J. Clin. Med. 9, 3527. https:\/\/doi.org\/10.3390\/jcm9113527 (2020).","journal-title":"J. Clin. Med."},{"key":"21845_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen, J., Melero, I. & Fridman, W. H. Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front. Immunol. 11, 951. https:\/\/doi.org\/10.3389\/fimmu.2020.00951 (2020).","journal-title":"Front. Immunol."},{"key":"21845_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5607\/en23019","volume":"32","author":"SR Choi","year":"2023","unstructured":"Choi, S. R. et al. NAG-1\/GDF-15 Transgenic female mouse shows delayed peak period of the second phase nociception in formalin-induced inflammatory pain. Exp. Neurobiol. 32, 247\u2013258. https:\/\/doi.org\/10.5607\/en23019 (2023).","journal-title":"Exp. Neurobiol."},{"key":"21845_CR27","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3892\/etm.2021.10705","volume":"22","author":"WW Jiang","year":"2021","unstructured":"Jiang, W. W. et al. Emerging roles of growth differentiation factor-15 in brain disorders. Exp. Ther. Med. 22, 1270. https:\/\/doi.org\/10.3892\/etm.2021.10705 (2021).","journal-title":"Exp. Ther. Med."},{"key":"21845_CR28","doi-asserted-by":"publisher","first-page":"28653","DOI":"10.1038\/srep28653","volume":"6","author":"DD Liu","year":"2016","unstructured":"Liu, D. D. et al. Growth differentiation factor-15 promotes glutamate release in medial prefrontal cortex of mice through upregulation of T-type calcium channels. Sci. Rep. 6, 28653. https:\/\/doi.org\/10.1038\/srep28653 (2016).","journal-title":"Sci. Rep."},{"key":"21845_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s12264-021-00709-5","volume":"37","author":"W Lin","year":"2021","unstructured":"Lin, W. et al. Growth differentiation factor-15 produces analgesia by inhibiting tetrodotoxin-resistant Nav1.8 sodium channel activity in rat primary sensory neurons. Neurosci. Bull. 37, 1289\u20131302. https:\/\/doi.org\/10.1007\/s12264-021-00709-5 (2021).","journal-title":"Neurosci. Bull."},{"key":"21845_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1471-4159.2005.03372.x","volume":"95","author":"Z Li","year":"2005","unstructured":"Li, Z. et al. Identification, expression and functional characterization of the GRAL gene. J. Neurochem. 95, 361\u2013376. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03372.x (2005).","journal-title":"J. Neurochem"},{"key":"21845_CR31","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat. Med. 13, 1333\u20131340. https:\/\/doi.org\/10.1038\/nm1677 (2007).","journal-title":"Nat. Med."},{"key":"21845_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cmet.2019.12.004","volume":"31","author":"T Borner","year":"2020","unstructured":"Borner, T. et al. GDF15 induces anorexia through nausea and emesis. Cell. Metab. 31, 351\u2013362e5. https:\/\/doi.org\/10.1016\/j.cmet.2019.12.004 (2020).","journal-title":"Cell. Metab."},{"key":"21845_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.tem.2020.10.004","volume":"31","author":"L Rochette","year":"2020","unstructured":"Rochette, L. et al. Insights into mechanisms of GDF15 and receptor GFRAL: therapeutic targets. Trends Endocrinol. Metab. 31, 939\u2013951. https:\/\/doi.org\/10.1016\/j.tem.2020.10.004 (2020).","journal-title":"Trends Endocrinol. Metab."},{"key":"21845_CR34","doi-asserted-by":"publisher","first-page":"bnaa007","DOI":"10.1210\/endrev\/bnaa007","volume":"41","author":"SM Lockhart","year":"2020","unstructured":"Lockhart, S. M., Saudek, V. & O\u2019Rahilly, S. GDF15: a hormone conveying somatic distress to the brain. Endocr. Rev. 41, bnaa007. https:\/\/doi.org\/10.1210\/endrev\/bnaa007 (2020).","journal-title":"Endocr. Rev."},{"key":"21845_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12967-019-02153-6","volume":"17","author":"A Melvin","year":"2019","unstructured":"Melvin, A. et al. Circulating levels of GDF15 in patients with myalgic encephalomyelitis\/chronic fatigue syndrome. J. Transl Med. 17, 409. https:\/\/doi.org\/10.1186\/s12967-019-02153-6 (2019).","journal-title":"J. Transl Med."},{"key":"21845_CR36","first-page":"1","volume":"8","author":"GAO Abdulridha","year":"2024","unstructured":"Abdulridha, G. A. O., Hussein, M. A. & Majeed, S. R. High growth differentiation factor-15 (GDF-15) in rheumatoid arthritis patients potential risk for cardiovascular disease. J. Angiother. 8, 1\u20138 (2024).","journal-title":"J. Angiother"},{"key":"21845_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","volume":"290","author":"D Mendieta","year":"2016","unstructured":"Mendieta, D. et al. IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients. J. Neuroimmunol. 290, 22\u201325. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.11.011 (2016).","journal-title":"J. Neuroimmunol."},{"key":"21845_CR38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/s0196-9781(00)00219-9","volume":"21","author":"Z Liu","year":"2000","unstructured":"Liu, Z. et al. A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid. Peptides 21, 853\u2013860. https:\/\/doi.org\/10.1016\/s0196-9781(00)00219-9 (2000).","journal-title":"Peptides"},{"key":"21845_CR39","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/art.1780371106","volume":"37","author":"IJ Russell","year":"1994","unstructured":"Russell, I. J. et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 37, 1593\u20131601. https:\/\/doi.org\/10.1002\/art.1780371106 (1994).","journal-title":"Arthritis Rheum."},{"key":"21845_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0304-3959(88)90019-X","volume":"32","author":"H Vaer\u00f8y","year":"1988","unstructured":"Vaer\u00f8y, H. et al. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 32, 21\u201326. https:\/\/doi.org\/10.1016\/0304-3959(88)90019-X (1988).","journal-title":"Pain"},{"key":"21845_CR41","doi-asserted-by":"publisher","first-page":"945513","DOI":"10.3389\/fimmu.2022.945513","volume":"13","author":"JP Sanabria-Mazo","year":"2022","unstructured":"Sanabria-Mazo, J. P. et al. Immune-inflammatory and hypothalamic-pituitary-adrenal axis biomarkers are altered in patients with non-specific low back pain: a systematic review. Front. Immunol. 13, 945513. https:\/\/doi.org\/10.3389\/fimmu.2022.945513 (2022).","journal-title":"Front. Immunol."},{"key":"21845_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10194-023-01563-8","volume":"24","author":"J He","year":"2023","unstructured":"He, J. et al. FGF-21 and GDF-15 are increased in migraine and associated with the severity of migraine-related disability. J. Headache Pain. 24, 28. https:\/\/doi.org\/10.1186\/s10194-023-01563-8 (2023).","journal-title":"J. Headache Pain"},{"key":"21845_CR43","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1515\/cclm-2022-0135","volume":"60","author":"P Welsh","year":"2022","unstructured":"Welsh, P. et al. Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort. Clin. Chem. Lab. Med. 60, 1820\u20131829. https:\/\/doi.org\/10.1515\/cclm-2022-0135 (2022).","journal-title":"Clin. Chem. Lab. Med."},{"key":"21845_CR44","doi-asserted-by":"publisher","first-page":"13824","DOI":"10.1038\/s41598-025-98028-6","volume":"15","author":"Y Mei","year":"2025","unstructured":"Mei, Y. et al. The association between serum growth differentiation factor 15 and insulin resistance in women diagnosed with polycystic ovary syndrome. Sci. Rep. 15, 13824. https:\/\/doi.org\/10.1038\/s41598-025-98028-6 (2025).","journal-title":"Sci. Rep."},{"key":"21845_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5114\/pm.2014.43818","volume":"13","author":"AM Malutan","year":"2014","unstructured":"Malutan, A. M. et al. Proinflammatory and anti-inflammatory cytokine changes related to menopause. Prz Menopauzalny. 13, 162\u2013168. https:\/\/doi.org\/10.5114\/pm.2014.43818 (2014).","journal-title":"Prz Menopauzalny"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21845-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21845-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21845-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:20:03Z","timestamp":1761830403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21845-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21845-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Recep Tayyip Erdo\u011fan University Non-Interventional Clinical Research Ethics Committee (Approval No: 2024\/39, Approval Date: 08 February 2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the subjects involved in this study, and written informed consent was obtained from the patients to publish this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}],"article-number":"38004"}}